These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8995505)

  • 21. The antileukemic alkaloid fagaronine is an inhibitor of DNA topoisomerases I and II.
    Larsen AK; Grondard L; Couprie J; Desoize B; Comoe L; Jardillier JC; Riou JF
    Biochem Pharmacol; 1993 Oct; 46(8):1403-12. PubMed ID: 8240389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells.
    Jacob S; Aguado M; Fallik D; Praz F
    Cancer Res; 2001 Sep; 61(17):6555-62. PubMed ID: 11522654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11.
    Kawato Y; Aonuma M; Hirota Y; Kuga H; Sato K
    Cancer Res; 1991 Aug; 51(16):4187-91. PubMed ID: 1651156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Camptothecin and minor-groove binder hybrid molecules: synthesis, inhibition of topoisomerase I, and anticancer cytotoxicity in vitro.
    Zhao R; al-Said NH; Sternbach DL; Lown JW
    J Med Chem; 1997 Jan; 40(2):216-25. PubMed ID: 9003520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-based analysis of the effects of camptothecin on the activities of human topoisomerase I.
    Champoux JJ
    Ann N Y Acad Sci; 2000; 922():56-64. PubMed ID: 11193925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons.
    D'Arpa P; Beardmore C; Liu LF
    Cancer Res; 1990 Nov; 50(21):6919-24. PubMed ID: 1698546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of topoisomerase I function by nitidine and fagaronine.
    Wang LK; Johnson RK; Hecht SM
    Chem Res Toxicol; 1993; 6(6):813-8. PubMed ID: 8117920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of action of camptothecin.
    Liu LF; Desai SD; Li TK; Mao Y; Sun M; Sim SP
    Ann N Y Acad Sci; 2000; 922():1-10. PubMed ID: 11193884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nascent DNA Proteomics Reveals a Chromatin Remodeler Required for Topoisomerase I Loading at Replication Forks.
    Ribeyre C; Zellweger R; Chauvin M; Bec N; Larroque C; Lopes M; Constantinou A
    Cell Rep; 2016 Apr; 15(2):300-9. PubMed ID: 27050524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sequence-selective DNA cleavage by a topoisomerase I poison, NB-506.
    Fukasawa K; Komatani H; Hara Y; Suda H; Okura A; Nishimura S; Yoshinari T
    Int J Cancer; 1998 Jan; 75(1):145-50. PubMed ID: 9426703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular and cytotoxic effects of camptothecin, a topoisomerase I inhibitor, on trypanosomes and Leishmania.
    Bodley AL; Shapiro TA
    Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3726-30. PubMed ID: 7731973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Camptothecin, a specific inhibitor of type I DNA topoisomerase, induces DNA breakage at replication forks.
    Avemann K; Knippers R; Koller T; Sogo JM
    Mol Cell Biol; 1988 Aug; 8(8):3026-34. PubMed ID: 2850477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of topoisomerase poisoning by antitumor drugs VM 26, fostriecin and camptothecin on DNA repair replication by mammalian cell extracts.
    Frosina G; Rossi O
    Carcinogenesis; 1992 Aug; 13(8):1371-7. PubMed ID: 1323426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro.
    Bowman KJ; Newell DR; Calvert AH; Curtin NJ
    Br J Cancer; 2001 Jan; 84(1):106-12. PubMed ID: 11139322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sensitivity to camptothecin of human breast carcinoma and normal endothelial cells.
    Jones CB; Clements MK; Wasi S; Daoud SS
    Cancer Chemother Pharmacol; 1997; 40(6):475-83. PubMed ID: 9332461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of camptothecin resistance by human topoisomerase I mutations.
    Chrencik JE; Staker BL; Burgin AB; Pourquier P; Pommier Y; Stewart L; Redinbo MR
    J Mol Biol; 2004 Jun; 339(4):773-84. PubMed ID: 15165849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression, purification, and characterization of DNA polymerases involved in papovavirus replication.
    Malkas LH; Hickey RJ
    Methods Enzymol; 1996; 275():133-67. PubMed ID: 9026636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DX-8951f, a water-soluble camptothecin analog, exhibits potent antitumor activity against a human lung cancer cell line and its SN-38-resistant variant.
    Joto N; Ishii M; Minami M; Kuga H; Mitsui I; Tohgo A
    Int J Cancer; 1997 Aug; 72(4):680-6. PubMed ID: 9259410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of topoisomerase inhibitor-induced DNA strand breaks and apoptosis by the alkaline comet assay.
    Godard T; Deslandes E; Sichel F; Poul JM; Gauduchon P
    Mutat Res; 2002 Sep; 520(1-2):47-56. PubMed ID: 12297143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlations between S and G2 arrest and the cytotoxicity of camptothecin in human colon carcinoma cells.
    Goldwasser F; Shimizu T; Jackman J; Hoki Y; O'Connor PM; Kohn KW; Pommier Y
    Cancer Res; 1996 Oct; 56(19):4430-7. PubMed ID: 8813137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.